S
SAB Biotherapeutics Inc
NASDAQ:SABS
SAB Biotherapeutics Inc
NASDAQ:SABS
Price:
3.57
USD
-5.8%
Market Closed
Market Cap:
$170m
Balance Sheet
Balance Sheet Decomposition
SAB Biotherapeutics Inc
SAB Biotherapeutics Inc
Balance Sheet Decomposition is not available for
SAB Biotherapeutics Inc
SAB Biotherapeutics Inc
Balance Sheet
SAB Biotherapeutics Inc
SAB Biotherapeutics Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
13
|
33
|
15
|
57
|
9
|
|
| Cash Equivalents |
13
|
33
|
15
|
57
|
9
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
12
|
|
| Total Receivables |
21
|
8
|
6
|
0
|
0
|
|
| Accounts Receivables |
21
|
8
|
6
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
9
|
1
|
2
|
3
|
|
| Total Current Assets |
34
|
50
|
22
|
59
|
24
|
|
| PP&E Net |
22
|
31
|
28
|
25
|
20
|
|
| PP&E Gross |
22
|
31
|
28
|
25
|
20
|
|
| Accumulated Depreciation |
2
|
3
|
6
|
10
|
15
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
57
N/A
|
81
+44%
|
51
-37%
|
84
+65%
|
44
-47%
|
|
| Liabilities | ||||||
| Accounts Payable |
7
|
4
|
4
|
1
|
2
|
|
| Accrued Liabilities |
3
|
13
|
10
|
7
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
2
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
7
|
0
|
1
|
0
|
|
| Total Current Liabilities |
11
|
26
|
15
|
11
|
8
|
|
| Long-Term Debt |
4
|
4
|
4
|
3
|
3
|
|
| Other Liabilities |
2
|
12
|
1
|
12
|
7
|
|
| Total Liabilities |
18
N/A
|
43
+143%
|
20
-53%
|
27
+34%
|
18
-32%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
12
|
29
|
48
|
90
|
124
|
|
| Additional Paid In Capital |
51
|
68
|
84
|
153
|
156
|
|
| Treasury Stock |
0
|
0
|
6
|
6
|
6
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
39
N/A
|
39
-1%
|
31
-19%
|
57
+84%
|
26
-55%
|
|
| Total Liabilities & Equity |
57
N/A
|
81
+44%
|
51
-37%
|
84
+65%
|
44
-47%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
3
|
4
|
5
|
9
|
9
|
|
Switch to:
Switch to:
See Also
Discover More
